Chest Rub

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of cough due to the common cold when applied to the chest and throat. Additionally, it is indicated for the temporary relief of minor aches and pains when applied to muscles and joints.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, a thick layer of the product should be applied to the chest and throat, or it may be rubbed onto sore, aching muscles. If desired, the area can be covered with a warm, dry cloth to enhance the effect. It is recommended to keep clothing loose around the throat and chest to facilitate the release of vapors to the nose and mouth. This application may be repeated up to three times within a 24-hour period, or as directed by a healthcare professional.

For children under 2 years of age, it is advised to consult a doctor before use.

Contraindications

Use of this product is contraindicated in the following situations:

Administration by mouth is prohibited. The product should not be applied with tight bandages, in nostrils, or on wounds or damaged skin due to the potential for adverse effects in these areas.

Additionally, the product must not be subjected to heat, including microwaving or adding to hot water or any container where heating water is involved. Such actions may lead to splattering and result in burns.

Warnings and Precautions

For external use only; direct contact with the eyes must be avoided to prevent irritation or injury.

In the event of accidental ingestion, it is imperative to seek immediate medical assistance or contact a Poison Control Center. Prompt action is crucial to ensure safety and mitigate potential risks associated with ingestion.

Healthcare professionals should advise patients to discontinue use and consult a physician if muscle aches and pains persist for more than seven days or if they recur. Additionally, if a cough lasts longer than seven days, returns, or is accompanied by fever, rash, or a persistent headache, patients should be instructed to seek medical evaluation, as these symptoms may indicate a serious underlying condition.

Emergency medical help should be sought without delay in cases of accidental ingestion, reinforcing the importance of immediate intervention in such scenarios.

Side Effects

Patients should be aware that the product is intended for external use only and must be kept away from the eyes to prevent irritation or injury.

In clinical practice, patients are advised to discontinue use and consult a healthcare professional if muscle aches and pains persist for more than 7 days or if they recur. Additionally, if a cough lasts longer than 7 days, returns, or is accompanied by fever, rash, or a persistent headache, these symptoms may indicate a serious underlying condition that requires medical evaluation.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Chest Rub (camphor, eucalyptus oil, menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the recommended application involves rubbing a thick layer on the chest and throat or on sore, aching muscles. It is advised to cover the area with a warm, dry cloth if desired and to keep clothing loose around the throat and chest to facilitate the release of vapors. This application may be repeated up to three times within a 24-hour period or as directed by a healthcare provider.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is essential to evaluate the potential risks and benefits associated with the use of this drug during pregnancy and lactation. Healthcare providers should consider the available data and individual patient circumstances when advising on the use of this medication in these populations.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may require dosage adjustments to ensure safety and efficacy. It is essential to monitor renal function tests in these individuals to assess their kidney status. Additionally, a reduced dose should be considered for patients with decreased creatinine clearance to mitigate the risk of adverse effects associated with impaired renal function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and clinical status, and initiate supportive care as necessary. It is crucial to gather information regarding the substance involved, the amount ingested, and the time of exposure to guide further management.

Management strategies may include activated charcoal administration if the patient presents within a suitable timeframe and is not at risk for aspiration. In cases of severe toxicity, specific antidotes may be indicated, and consultation with a poison control center or toxicology expert is advised.

Continuous monitoring of the patient’s condition is essential, and symptomatic treatment should be provided as needed. Documentation of the incident and the management steps taken is also important for ongoing patient care and future reference.

Healthcare professionals are encouraged to report any cases of overdose to the appropriate regulatory authorities to contribute to the understanding of the substance's safety profile.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of accidental ingestion of the medication. It is important for patients to understand the urgency of this action to ensure their safety and well-being.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers assigned for identification. It is essential to adhere to the recommended storage conditions to ensure product integrity and efficacy.

The product should be stored at controlled room temperature, typically defined as 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). It is crucial to protect the product from light and moisture, and it should be kept in its original container until use to maintain stability.

Special handling precautions must be observed to prevent any potential degradation of the product. Failure to follow these warnings could result in serious consequences.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Chest Rub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)